June 2026
The global neurological rare disease biologics market is growing as advanced biologics address unmet needs in rare neurological disorders.
September 2026
The rare disease small-batch CDMO market is expanding with demand for specialized manufacturing of orphan drugs and niche therapies.
June 2026
The rare diseases treatment market size was estimated at USD 244.57 billion in 2025 and is predicted to hit around USD 566.83 billion by 2035 with a CAGR of 8.77%.
September 2026
The global artificial intelligence (AI) in inflammatory bowel disease market is surging, with an overall revenue growth expectation of hundreds of millions of dollars from 2026 to 2034.
September 2026
The infectious respiratory disease diagnostics market size was USD 60.62 billion in 2026, with leading infectious respiratory disease diagnostics market players including F. Hoffmann - La Roche, Thermo Fisher Scientific, Danaher (Cepheid), Abbott LaboratoriesÂ
September 2026
The global sickle cell disease treatment market size is predicted to hit around USD 15.81 billion by 2035 from USD 4.35 billion in 2026 with a CAGR of 15.48%.
September 2026
The near infrared absorbing materials market size is predicted to reach around USD 722.31 million by 2034 from USD 366.95 million in 2026 with a solid CAGR of 7.83%.
September 2026
The rare earth minerals market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
September 2026
The orphan disease biomarkers market expands with advancements in genomics, proteomics, and bioinformatics for rare conditions.
September 2026
The rare musculoskeletal disorder treatments market is growing as innovation targets therapies for underserved and complex conditions.
September 2026
The global inflammatory bowel disease treatment market size is projected to hit around USD 32.46 billion by 2035 from USD 22.38 billion in 2025, with a CAGR of 3.79%.
September 2026
The global non-dispersive infrared market size is valued at USD 808.14 million in 2026 and is estimated to hit around USD 1391.66 million by 2034 with a CAGR of 7.03%.
September 2026
The global infectious disease molecular diagnostics market size is estimated to hit around USD 63.37 billion by 2034 with a CAGR of 3.25% from 2026 to 2034.
September 2026
The global sexually transmitted diseases diagnostics market size is estimated to hit around USD 21.44 billion by 2034 from USD 12.26 billion in 2026, with a CAGR of 7.24%.
September 2026
The global biologics and biosimilars market size is estimated to hit around USD 2,426.85 billion by 2035 increasing from USD 700.76 billion in 2026, with a CAGR of 14.80%.
September 2026
The lyme disease diagnostic devices market size accounted for USD 2.97 billion in 2026 and is predicted to hit around USD 4.79 billion by 2035, with a CAGR of 5.44%.
September 2026
The global biologics CDMO market size was valued at USD 25.08 billion in 2026 and is projected to hit around USD 55.11 billion by 2035 with a healthy CAGR of 9.14%.
September 2026
The global next-generation biologics market size was evaluated at USD 135.12 billion in 2026 and is predicted to hit around USD 301.22 billion by 2034, growing at a CAGR of 10.54% from 2025 to 2034.
September 2026
The australia rare earth minerals market established a strong position in 2026 and is projected to expand significantly from 2026 through 2035, driven by increasing demand, evolving market needs, technological advancements, and growing adoption across key industries..
September 2026
The global periodontal disease treatment market size was evaluated at USD 3.17 billion in 2026 and is predicted to hit around USD 6.23 billion by 2035, growing at a CAGR of 7.80%.
September 2026
The global enteric disease testing market size was evaluated at USD 4.58 billion in 2026 and is predicted to hit around USD 8.09 billion by 2035, growing at a CAGR of 6.52%.
September 2026
The global inflammatory disease market size was evaluated at USD 133.50 billion in 2026 and is predicted to hit around USD 241.34 billion by 2035, growing at a CAGR of 6.80%.
September 2026
The parkinsons disease biomarkers market size reached USD 1.54 billion in 2026, with leading parkinsons disease biomarkers market companies including F. Hoffmann-La Roche Ltd., Bio-Rad Laboratories, Thermo Fisher Scientific, Abbott Laboratories.
September 2026
The global Alzheimers disease diagnostics market size was evaluated at USD 10.42 billion in 2026 and is predicted to hit around USD 26.21 billion by 2035, growing at a CAGR of 10.80%.
September 2026
The autoimmune neurological disorders market generated USD 9.17 billion in 2026, with prominent autoimmune neurological disorders market companies including Biogen Inc., F. Hoffmann-La Roche Ltd., Novartis AG, Sanofi S.A.
September 2026
The global Huntingtons disease market size was evaluated at USD 1.66 billion in 2026 and is predicted to hit around USD 6.48 billion by 2035, growing at a CAGR of 17.20%.
September 2026
The U.S. biologics market was worth USD 223.60 billion in 2026, with key U.S. biologics market players including Eli Lilly & Company, Samsung Biologics, F Hoffman La Roche.
September 2026
The stem cell therapy for neurological disorders market generated USD 17.90 billion in 2026, with prominent stem cell therapy for neurological disorders market companies including BrainStorm Cell Therapeutics, Mesoblast, ReNeuron Group.
September 2026
The global remote neurological monitoring market size was evaluated at USD 2.81 billion in 2026 and is predicted to hit around USD 9.69 billion by 2035, growing at a CAGR of 14.80%.
September 2026
The wound care biologics market size is expected to surpass around USD 11.22 billion by 2034, increasing from USD 6.65 billion in 2026, with a CAGR of 6.75%
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com